Articles of note for people dealing with pituitary disease and related conditions.
The latest from pharmaceutical companies and healthcare organizations
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Inside Camurus: Dr. Markus Johnsson talks about FluidCrystal® technology and next-generation treatment innovations
In the latest episode of the Pituitary World News podcast, Jorge D. Faccinetti sits down with Dr. Markus Johnsson, Senior VP of R&D at Camurus, to explore the fascinating world of FluidCrystal® technology. This innovative approach promises to revolutionize the way we think about drug delivery, providing long-lasting solutions for chronic diseases particularly for people with acromegaly.
Is Your Pituitary Tumor Genetic? Key Signs and Testing Guidelines
We’re delighted to share this article by Dr. Jennifer Perkins on genetics and pituitary disease, a subject of great interest
Worth noting:
From Debiopharm, read about Oxtent™ 3 clinical trial for acromegaly for a long term (3-month) octreotide treatment. More information here.
From Camurus more information on a new treatment option for acromegaly. Read more here
From Crinetics Pharmaceuticals – FDA approves Crinetics PALSONIFY™ for adults with acromegaly . Read more
Recordati announces FDA approval of ISTURISA® new indication in the U.S. to treat endogenous hypercortisolemia in patients with Cushing’s syndrome,- Learn more here
New support site from Chiesi; Rethink acromegaly
Pfizer announces Together with Acromegaly patient support site.
Chiesi relaunches a patient-facing website for Mycapssa.
Content for physicians and healthcare professionals.
Join a drug trial. Find out how. Here’s a partial list of studies.
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D. Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
In today’s podcast, Dr. Lewis Blevins dives into the fascinating findings from a study by Corcept Therapeutics on the prevalence of hypercortisolism in people with type 2 diabetes.
Apple Podcasts
Spotify
Amazon Music
Google PodcastsEvents
